Search Results for "dimethyl fumarate"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for dimethyl fumarate. Results 11 to 12 of 12 total matches.
See also: Tecfidera

Cladribine (Mavenclad) for Multiple Sclerosis

   
The Medical Letter on Drugs and Therapeutics • Jul 29, 2019  (Issue 1577)
), dimethyl fumarate (Tecfidera), and siponimod (Mayzent) are convenient alternatives to parenteral drugs ...
The FDA has approved cladribine (Mavenclad – EMD Serono), a purine antimetabolite, for oral treatment of adults with relapsing forms of multiple sclerosis (MS), including relapsing-remitting disease and active secondary progressive MS (SPMS), who cannot tolerate or have had an inadequate response to other drugs indicated for treatment of MS. It is not recommended for use in patients with clinically isolated syndrome (CIS). IV cladribine, which is FDA-approved for treatment of hairy cell leukemia, has been used off-label for treatment of MS.
Med Lett Drugs Ther. 2019 Jul 29;61(1577):118-20 |  Show IntroductionHide Introduction

New Drugs for Multiple Sclerosis

   
The Medical Letter on Drugs and Therapeutics • Nov 12, 2012  (Issue 1403)
treatment. BG-12, an oral formulation of dimethyl fumarate, activates an antioxidant pathway, reducing ...
In recent years, several new drugs have been approved by the FDA for use in multiple sclerosis (MS), and many others are in the pipeline. Most recently, teriflunomide (Aubagio – Genzyme) became the second oral drug to be approved by the FDA for treatment of relapsing forms of MS.
Med Lett Drugs Ther. 2012 Nov 12;54(1403):89-91 |  Show IntroductionHide Introduction